01-11-2008
Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial)
Published in: Neuroscience and Behavioral Physiology | Issue 9/2008
Login to get access